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Summary Immunoglobulin (Ig) could not be detected on the surface or in the cytoplasm of neoplastic cells from five cases of follicle centre cell lymphoma with centroblastic/centrocytic follicular histology when
examined by immunohistology of frozen or wax embedded sections. Examination by fluorescein labelled
antibodies of cells in suspensions prepared from the biopsies revealed a monotypic surface Ig positive
population in one case and a surface or cytoplasmic Ig K:A light chain imbalance in a further two cases
consistent with neoplastic B cell involvement: in all cases the proportion of cells failing to express Ig or T cell
markers ranged from 24 to 75%. The monoclonal antibodies Bl (Pan B cell), FMC4 (HLA class II) and J5
(cALL antigen) stained the majority of cells in suspension with residual cells staining with UCHT1 or OKT1I (T cell monoclonal antibodies). In frozen sections, neoplastic follicular cells did not stain with UCHT1.
However, in the one case tested these cells stained with the antibodies B1 and FMC4. In paraffin sections J chain could be demonstrated in the cytoplasm of three out of five cases. Cells from four cases were cultured
in vitro for Ig production: two failed to produce Ig and monotypic light chains were the sole Ig product of the
remaining two cases.
The failure to express Ig by the majority of the neoplastic cells from the cases described in this report is at variance with the follicular histology of these neoplasms. Mechanisms responsible for this failure are discussed
with reference to current models of B cell differentiation.
Normal lymphocyte development is accompanied
by sequential changes in cellular enzyme content
and surface antigen expression. In the B
lymphocytic lineage the best characterized of these
are changes in immunoglobulin (Ig) synthesis,
expression and secretion. The earliest event which
distinguishes B cells is the rearrangement of Ig
heavy chain (HC) genes and subsequent expression
of cytoplasmic p (c,) chains (Raff et al., 1976;
Burrows et al., 1979). This is followed by
rearrangement of Ig light chain (LC) genes and the
expression of surface membrane Ig (slg), initially
slg M followed by sIg D (Osmand & Nossal, 1974).
Further development is usually accompanied by
heavy chain class switching and an increase in Ig
secretion, both of these effects being antigen and/or
factor dependent (Melchers et al., 1982).
Current classifications of non-Hodgkin's
lymphoma (NHL) relate the neoplastic cell type to
simplified schemes of normal lymphocyte
maturation. The Kiel classification of B cell NHL
(Gerard-Marchant et al., 1974) distinguishes two
predominant cell types in lymphoid follicles, large
and small cleaved centrocytes (cc) and large and
small non-cleaved centroblasts (cb) The neoplastic
analogues of these cell types are found as mixtures
forming neoplastic follicles or in diffuse sheets
effacing the normal architecture of the lymph node.
The diagnosis and classification of NHL has been
facilitated by the demonstration of cell markers in
sections and on isolated cells prepared from biopsy
tissue. One of the most valuable markers for
neoplastic lymphocytes of the B cell lineage is the
demonstration of monotypic slg and/or clg,
although many monoclonal antibodies to non Ig
determinants have also proved to be of value. The
assay of Ig production by cells in culture can
provide additional information where the slg
isotype is either difficult to assess or absent
(Hannam-Harris et al., 1980).
In this paper we report the findings in five cases
of follicular cb/cc NHL, in which the majority of
the neoplastic cells failed to express sIg or clg or
produce Ig in vitro.
Materials and methods
Biopsies
Lymph node biopsy material was collected fresh
and divided for routine histology, frozen sections
and preparation of cell suspensions as described by Stevenson et al. (1983).
Paraffin sections
Sections of routine formalin fixed paraffin
embedded material were deparaffinized in xylol and
taken to alcohol. Endogeneous peroxidase activity
was inhibited with 0.5% hydrogen peroxide in
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methanol and the sections were washed in water
and treated for 15min with a solution of 0.1%
trypsin in 0.1% calcium chloride pH 7.8 (Mepham
et al., 1979). The sections were washed with
agitation in cold distilled water and further rinsed
in tris buffered saline (TBS) pH 7.8, followed by a
30min incubation with rabbit antiserum to
immunoglobulin determinants or J chain (see
below). Sections were given a further three washes
in TBS before incubation with swine anti-rabbit
antibody followed by a thirty minute incubation
with rabbit peroxidase-anti-peroxidase (PAP,
Dakopatts) complexes at appropriate dilutions.
Specific staining was demonstrated by the
development of brown coloration on incubation
with diaminobenzidine (DAB). The sections were
counterstained with Mayers haematoxlin and
differentiated in 1% acid alcohol. Appropriate
controls were performed for each layer of the
immunostaining technique and for the specificity of
the antibody.
Frozen sections
Fresh biopsy material was snap frozen and stored
in liquid nitrogen. Six gm cryostat sections were air
dried for 30min at room temperature and stored
over silica gel at -20°C in an airtight container
until stained. Frozen sections were allowed to reach
room temperature and fixed in dry acetone for
20min. The sections were then immediately
transferred to TBS, drained and incubated for
30min with rabbit antisera to human Ig or with
monoclonal antibodies directed against other cell
surface determinants (see below). This was followed
with 3 washes in TBS and incubation with
peroxidase conjugated rabbit anti-mouse Ig or with
the two stages of PAP reagent as appropriate. After
a further 3 washes in PBS sections were incubated
with DAB, and counterstained in Harris's
haematoxylin (Stein et al., 1980).
Cell suspensions
Fresh biopsy material was minced through sterile
wire mesh and a cell suspension prepared by
density gradient centrifugation over ficoll-triosil as
described previously (Payne et al., 1977). Cells
collected at the interface were washed 3 times in
PBS. In all cases viability was >90% by trypan
blue exclusion. Cells were incubated for 30min at
37°C and washed once in minimal essential medium
(MEM, Flow Laboratories) containing 10% foetal
calf serum (FCS, Sera Laboratories), also at 37°C,
to remove cytophilic antibody. The cell suspensions
were investigated for T and B markers and Ig
synthesis in culture.
The rosette test for the indentification of T cells
with receptors for sheep erythrocytes (E) has been
described previously (Payne et al., 1977). Surface Ig
was characterized by staining cell suspensions with
fluorescein conjugated rabbit antisera to Ig heavy
and light chain determinants. Mouse monoclonal
antibodies direct against T and B cell determinants
were used when sufficient cells were recovered.
These antibodies were used in an indirect
fluorescent antibody assay with fluorescein
conjugated rabbit antibody to mouse Ig as second
antibody. Details of antibodies are given separately.
Cytospin preparations fixed in methanol and
washed with PBS were stained with fluorescein
conjugated antisera for the detection of clg heavy
or light chains. Appropriate controls were included
in each batch of stains. The fluorescein labelled
preparations were examined using a Leitz labolux
12 microscope fitted with an HBO 50w mercury
vapour ploempak fluorescence vertical illuminator.
Diagnostic antibodies
Polyclonal antibodies used in this study were:
fluorescein conjugated and unconjugated rabbit
antibodies to Ig heavy and light chains (K, A, y, j,
or a chain specific; Dakopatts), rabbit antibody to
J chain (Dakopatts), horseradish peroxidase and
fluorescein conjugated rabbit antibody to mouse Ig
(Dakopatts) and swine antibody to rabbit Ig
(Dakopatts).
Mouse monoclonal antibodies to T cells (Pan T
markers: UCHT1, (Beverley & Callard, 1981)
University College Hospital, London and OKT11
(Verbi et al., 1982) Orthodiagnostics), B cells (Pan
B marker, Bl (Stashenko et al., 1980)
Orthodiagnostics and a marker for a B cell subset
FMC7, (Catovsky et al., 1981) Sera Laboratories),
HLA-DR (FMC4, (Beckman et al., 1980) Sera
Laboratories), the CR1 (C3b) receptor, (El1, which
delinates dendritic reticulum cells, macrophages and
B cell subsets (El1, (Hogg et al., 1984)) and to the
common acute lymphoblastic (cALL) antigen (J5
(Ritz et al., 1980) Coulter Electronics). The mouse
monoclonal antibody, RF-Al, (gift from Professor
G. Janossy) reactive to T cells and a B cell subset
was also used in this study (Caligaris-Cappis et al.,
1982; Martin et al., 1981).
Cell culture
Cells were resuspended at 2 x 10 ml-I in Eagle's
MEM (Flow Laboratories) containing 10% heat
inactivated FCS, 1% non-essential amino acids,
2mM L-glutamine and 100IUml-1 of benzyl-
penicillin and streptomycin. The cells were incubated
at 37°C with gentle swirling for 6h. Aliquots were
removed at 0, 3 and 6h and viable cell numbers
assessed by trypan blue exclusion. The viable cell
numbers remained within 2% of the starting value
throughout the culture period. The cells wereIg-NEGATIVE FOLLICLE CENTRE CELL LYMPHOMA 737
pelleted by centrifugation at 250g for 10min and
the supernatants retained for determination of
Igproduction byenzyme linkedimmunosorbent assay
(ELISA) or radioimmunoassay (RIA).
Radioimmunoassay
The RIA system has been previously described by
one of us (Stevenson et al., 1980, 1981). Briefly
sheep antibodies to human Fd , ,, 6, Fab'yK or
Fab'yA were prepared and characterized as
described previously and were coupled to Sephadex
G-25 superfine beads (Pharmacia, Sweden) and
used as solid phase antibodies. Radiolabelled Fab y,
Fab i, Fab 6 and K or A light chains were used as
antigens. All were labelled with I125 (Amersham) by
the lactoperoxidase technique (Morrison et al.,
1971). Solid phase antibodies were incubated for
48 h at room temperature with labelled antigen and
unknown or standards in the presence of 0.5%
nonidet P40 (BDH) 1 mgml1 bovine haemoglobin
(BDH) and 20jugml-1 soyabean trypsin inhibitor
(BDH). After washing, counts associated with the
solid phase were determined on an LKB
rackgamma counter. These assays were sensitive to
the respective immunoglobulin components in the
range 1-200ngml -1.
Enzyme linked immunoabsorbent assay
The method is adapted from Engvall & Perlman
(1972). A triple layer sandwich technique was used.
Sheep antibodies to human Ig K, A, y, 6 and u
chains or Fd 6 were prepared and characterized
(Stevenson et al., 1980). Antibodies diluted in
Na2CO3/NaHCO3 buffer (pH 9.6) were coated
onto a 96 well flat bottomed, Nunc Immunoplate
(Gibco Europe Ltd., Uxbridge) by incubation for
60min at 37°C followed by 16h at 4°C. Uncoated
plastic was blocked by incubation with 1% BSA in
PBS for 60min at 370C. Plates were washed 4 times
with 0.1% Tween 20 (Koch Light Laboratories) in
PBS. Cell culture supernatants were added to
individual wells and the plate was incubated for
90min at 370C. The plates were again washed 4
times before incubation for 90min at 37°C with
horseradish peroxidase (HRP) conjugated antibody
of similar specificity to the coating antibody. (HRP
rabbit anti-human K and A chains, (Dakopatts);
HRP goat anti-human y, ,u, cx chains, (Sigma) and
HRP sheep anti-human Fd 6, (Stevenson et al.,
1980). All conjugated antibodies not raised in sheep
were absorbed with normal sheep IgG-prior to use
and were negative in control incubations. After a
further four washes colour was developed by the
addition of freshly prepared o-phenylenediamine
substrate in a phosphate: citric acid buffer (pH 5.0),
catalysed by the addition of H202. The reaction
was stopped by the addition of 2.5M sulphuric acid
and the absorbance at 490nm determined using a
Microelisa Auto Reader (Dynatech MR580).
These assays were sensitive to Ig products in the
range 1-25ngml-1 and were performed in triplicate
with positive and negative standards on each plate.
For each assay system antibodies were titrated to
give optimum sensitivity and these optimal values
were always used subsequently. Each new batch of
antibody was re-titrated.
Serum and urine Ig assay
Serum and urine were assayed by standard methods
for Ig levels, paraproteins and monoclonal urinary
light chains by routine methods previously
described (Stevenson et al., 1983).
Results
Marker studies
The results of marker studies carried out on both
frozen and paraffin embedded biopsies are given in
Table I. In frozen sections the neoplastic cells failed
to stain for Ig or with the T cell monoclonal
antibody (UCHTI). Cells staining with UCHTI
were scattered within neoplastic follicles and as a
rim around the follicle (Figure la). Polytypic Ig
staining cells were found in the interfollicular areas
and in the mantle zone (Figures lb and c)
surrounding the follicles. The antibody ElI stained
dendritic reticulum cells within the follicles but did
not stain the neoplastic cells (Figure ld). In JK the
sections were stained with BI and FMC4: these
antibodies stained both neoplastic cells within the
follicles and normal B cells in the interfollicular
areas.
No cytoplasmic Ig could be detected within
neoplastic cells embedded in paraffin sections,
however cytoplasmic J chain was detectable in 3
cases (LV, AT, SH) (Table I).
The results of marker studies carried out on cells
dispersed from biopsy material are given in Table
II. The slg staining of AT was consistent with a
predominant population of monotypic slg K
staining cells. In two other cases the number of cells
staining for slg K and A differed from the normal
ratio of 2:1, with a predominance of slg A cells (SH
and SA). In SH a predominant population of
cytoplasmic Ig M A positive cells was detectable. T
cells detectable by monoclonal antibody or E
rosetting were present in all preparations. The total
percentage of cells detectable by slg K and A
staining and T cell monoclonal antibody markers
was less than 100% in all cases examined and
ranged from 76% (SA) to 25% (JK). In LV, 87%
of the cells could be accounted for by E rosetting
and sIg K and A staining.738 E.O. GREGG et al.
Table I Immunohistochemical investigation of frozen and paraffin embedded material
Frozen section' Paraffin sectionsa
Patient Surface Ig UCH-TJ EJJC Cytoplasmic Igb Cytoplasmic J chain
JK Neoplastic follicles neg (+) + neg neg Interfollicular areas M,D
k,A + neg + +
LV Neoplastic follicles neg (±) n.d. neg +
Interfollicular areas M,D k,2 + n.d. + +
AT Neoplastic follicles neg (±) + neg +
Interfollicular areas M,D
k,A + neg + +
SH Neoplastic follicles neg (+) + neg +
Interfollicular areas M,D k,A + neg + +
SA Neoplastic follicles neg (+) + neg neg
Interfollicular areas M,D k,A + neg + +
'For details see methods.
bCytoplasmic staining was negative for all classes of Ig heavy and light chains in neoplastic follicles and
polyclonal in interfollicular areas.
'dendritic cell staining.
neg=no staining of cells seen.
n.d. =not done.
(+)=scattered positive cells within follicles see Figure 1.
Table II Markers on dispersed cells
% Cells expressing
Surface antigens detected by
Surface Ig type Cytoplasmic Ig monoclonal antibodies
Patient G A M D k i and light chains BJ FMC7 FMC4 J5 RFAI Ta E rosettes
JK O 0 8 3 10 5 2 (MGkA) 85 5 95 72 40 la 4 SH 3 0 20 4 13 15 12 (10A,2k, 12M) 63 5 50 67 55 35c 30 LV 4 0 11 6 6 1 0 nd nd nd nd nd nd 80 AT 17 7 30 21 43 6 0 69 3 65 61 91 308 18 SA 4 1 27 2 12 20 1 (MA) 79 18 65 53 82 44c 38
b 31 19 1 - - 48a
(12-44) (4-31) (0-5) (29-78)
nd=not done.
aUCH Ti.
bResults from ten cases of reactive lymphadenopathy:mean (range).
cOKT 11.
The monoclonal antibodies BI, J5 and FMC4
detected a predominant population of cells in the
four cases in which they were used (JK, SH, AT,
SA) (Table II). The total percentage of cells
detected by BI and the T cell markers accounted
for more than 95% of the cells in suspension from
all the cases tested, with a small overlap (23%)
between the numbers of cells detected by Bl and
OKT11 in cell suspensions from SA. The
proportion of cells stained by the monoclonal
antibody FMC4 ranged from 50% (SH) to 95%
(JK), similarly J5 stained 61% (AT) to 72% (JK) of
the cells in suspension. More than 82% of the cells
in JK, SH, AT and SA could be accounted for byFigure 1 Immunoperoxidase staining of frozen sections from case SA. The staining patterns are typical of the other cases in this study. (a) Section stained with UCH TI showing a rim of T cells around a neoplastic follicle with scattered T cells within the follicle (Immunoperoxidase x 300). (b) Section stained to show IgD. A narrow mantle of IgD positive cells is visible around the neoplastic follicle (Immunoperoxidase x 120). (c) Section stained to show IgM. A narrow mantle of IgM positive cells, similar to IgD, is visible around the
neoplastic follicle (Immunoperoxidase x 120). (d) Section stained with El 1. The neoplastic follicles contain a network of positively staining dendritic cells (Immunoperoxidase x 120).
739740 E.O. GREGG et al.
staining with FMC4 or J5 and the T cell mono-
clonal antibodies (Table II). Material was not
available from LV for monoclonal antibody studies.
The results of cell suspensions, prepared from
reactive lymph nodes, stained for sIg K and A and
the T cell monoclonal antibody, UCHTI, are given
in Table II for comparison.
Ig production
Cells from four of the five cases were available for
cell culture and assessment of Ig production (Table
III). Cell culture supernatants were assessed for K
and A light chains and for y, a, ,u and 6 heavy
chains as described in the methods. In two cases
(SH, AT) monotypic Ig light chain secretion was
found with no detectable whole Ig secretion. No
production of Ig was observed by cells from JK or
SA. Results from five typical cases of cb/cc
follicular lymphoma and from nine reactive lymph
nodes are given for comparison (Table III).
Table III Ig production by neoplastic cells
(ng per 2 x 107 cells at 6h)
Light chain
Patient Heavy chain k i
JK 0 0 0
SH 0 0 25
AT 0 19 0
SA 0 0 0
a 35 33
(11-96) (19-62) b nd 157
(38-586)
aResults from five typical cases of cb/cc
follicular lymphoma: mean (range).
Monotypic Ig light chain secretion was
found in all cases (3k:2A).
bResults from nine reactive lymph
nodes:mean (range). Polytypic Ig light chain
secretion was found in all cases; heavy chain
class was not determined (nd).
Serum and urine
Serum IgA, G, and M levels for all cases were
within normal range and there was no evidence for
a paraprotein. A search for monoclonal urinary Ig
light chain in concentrated urine revealed a trace K
light chain in JK. The remaining four patients did
not have detectable urinary light chains. None of
these patients had proteinuria.
Discussion
Cells of the follicle centre represent antigenically
stimulated B lymphocytes at an intermediate stage
of differentiation thought to be actively expressing
and secreting Ig (Wakefield & Thorbecke, 1968;
Grobler et al., 1974; Cooper et al., 1973). Studies
from this and other laboratories using similar
immunoperoxidase techniques for the detection of
Ig in tissue sections have shown that follicle centre
cells from normal reactive and neoplastic tonsils,
lymph nodes and spleen are either surface and/or
cytoplasmic Ig positive (Isaacson et al., 1980; Stein
et al., 1980, 1982). These data contrast with a
recent report from Hsu et al. (1983) who failed to
detect Ig expression by the majority of follicle
centre cells in frozen sections from normal reactive
tissue. Clearly methods need to be compared and
standardized for the detection of Ig in sections.
Recently Cordell et al. (1984) have drawn attention
to differences in sensitivity between techniques.
The large majority of cells in suspensions
prepared from reactive lymph nodes can be labelled
with the T cell monoclonal antibody, UCHT1, and
antibodies to Ig K and A chains (Table II). Data
from this and other laboratories have shown that
the majority of neoplastic cells in suspensions
prepared from cb/cc follicular NHL express slg and
occasionally clg predominantly of IgM isotype
(Payne et al., 1977; Leech et al., 1975; Godal &
Funderund, 1982).
Cell suspensions, prepared from biopsy tissue,
offer optimal conditions for the detection of sIg,
but may selectively enrich for normal or neoplastic
subpopulations. Consequently results obtained by
tissue section staining techniques or by staining of
dispersed cells in suspension will occasionally show
discrepancy. This discrepancy was clearly observed
in one case in this study (AT) where monotypic slg
was demonstrable on cells in suspension but not in
tissue section. A further two cases (SA & SH) also
negative for slg and clg in sections exhibited slg
and/or clg K:A light chain imbalance when cell
suspensions were examined suggestive of IgM A
neoplastic B cell involvement. Despite these
findings, slg was not detected on 24-75% of the
neoplastic cells, which failed to stain with
monoclonal antibodies to T cells, in JK, SH, AT
and SA.
In two cases (JK & LV) cell suspension analysis
and examination of tissue sections both failed to
demonstrate an Ig phenotype. E rosetting cells were
recovered in high numbers in suspensions prepared
from LV. In this particular case it was not possible
to decide whether we had failed to recover the
neoplastic population or if the E positive cells
represented a neoplastic B cell population withIg-NEGATIVE FOLLICLE CENTRE CELL LYMPHOMA 741
affinity for sheep erythrocytes (Prieur & Brouet,
1974).
The B cell nature of the neoplastic cells was
sought by using antibody probes for J chain and B
cell related antigens. J chain was demonstrable in
the cytoplasm of neoplastic cells in paraffin
embedded sections of LV, AT and SA, but was not
found in cells from JK & SH. The monoclonal
antibody Bi, which recognises a determinant widely
expressed throughout the B cell lineage (Stashenko
et al., 1980) and the monoclonal antibody FCM4,
which is specific for class II antigens (Beckman et
al., 1980), stained the majority of cells in frozen
sections from JK. The other cases were not tested.
In our experience both these antibodies reliably
stain normal and neoplastic B cells in lymphomas
of follicular histology. Bi stained the majority of
cells in suspensions prepared from JK, SH, AT and
SA, and together with the T cell monoclonal
antibody accounted for more than 95% of the cells.
A small population of cells expressing antigen
determinants recognised by Bi and OKT11 was
observed in SA. This population of cells is
analogous to previously reported neoplastic B cell
populations from a small number of malignant
lymphomas, which express the T cell antigen
recognised by OKTl1, (Aisenberg et al., 1981).
FMC4 stained the majority of cells in suspension
from JK, SH, AT and SA and together with the T
cell monoclonal antibody accounted for more than
85% of the cells. Neoplastic cell populations from
all five cases expressed one or more determinants
associated with B cells, consistent with these
tumours being of B cell origin.
The monoclonal antibody J5, which reacts with
cALL cells and some B and T cell lymphomas
including neoplastic and normal B cells of follicle
centres (Ritz et al., 1980, 1981; Habeshaw et al.,
1983; Stein et al., 1982), stained 53-72% of cells in
suspensions from JK, SH, AT and SA. This
antibody does not appear to react with T cells in
follicular lymphomas (Stein et al., 1982) and this
finding is a further demonstration of the similarity
of the neoplasms described in this report to other
cases of follicular lymphoma.
The majority of cells in suspension (82-97%)
from JK, SH, AT and SA were negative for the B
cell subset antibody FMC 7, which reacts
preferentially with neoplastic cells in
prolymphocytic leukaemia and variably with
neoplastic cells in lymphoma (Catovsky et al., 1981;
Collins et al., 1983). The monoclonal antibody RF-
Al which recognises T cells and a shared
determinant present on a normal B cell subset and
neoplastic B cells of CLL (Martin et al., 1981)
reacted with more cells than expected when tested
with cell suspensions prepared from the four cases.
A similar observation for cb/cc lymphoma of
follicular histology has been reported by Habeshaw
et al. (1983).
All of the lymphomas in this study showed
histology typical of follicle centre cell lymphoma,
cb/cc follicular. Lymphomas with this histology in
which the neoplastic cells do not express slg are
rare and represent less than 3% of follicular
tumours in our series. In a recent immuno-
histological study of NHL Tubbs et al. (1984)
found one Ig negative lymphoma with a follicular
histology in a group of 53 such cases examined, a
similar incidence to that in our own series.
Human "null" lymphocytes defined by a lack of
T lymphocyte markers and Ig expression have been
identified among mononuclear cells from normal
peripheral blood, lymph nodes and spleen. A brief
review of the earlier literature relating to this
subject can be found in Haegert & Coombs (1979).
In this article and a subsequent paper (Haegert,
1981) it is claimed that the majority of "null"
lymphocytes are of B cell lineage by virtue of
surface Ig demonstrable by the mixed antiglobulin
technique. Our earlier studies (Payne et al., 1977)
and the data relating to normal lymph node
populations presented in this paper support this
conclusion. Nevertheless whether all "null" cells
detected in these tissues bear slg and are therefore
of B cell lineage remains to be resolved. Technical
improvements such as those described by Haegert
(1981) and Cordell et al. (1984) together with the
application of T and B cell specific monoclonal
antibodies will help to resolve this problem.
Neoplastic "null" cells occur in ALL, CLL and
NHL. "Null" cells in CLL can be shown to be
capable of synthesizing Ig in vitro (Gordon et al.,
1978) thus providing evidence for their B cell origin
(Gordon, 1984). We have also shown that isolated
neoplastic cells from cases of follicular NHL secrete
whole Ig and/or free Ig light chains when cultured
in vitro (Hannam-Harris et al., 1982; Stevenson et
al., 1984). Neoplastic cells from four cases in this
study were investigated for their ability to secrete
Ig. Neoplastic cells from two of these, AT and SH
secreted monotypic Ig light chain but did not
secrete whole Ig in vitro. This pattern of Ig
secretion is unusual in follicular NHL and has been
associated with immature normal and neoplastic B
lymphocyte populations in CLL (Hannam-Harris et
al., 1980; Gordon et al., 1983).
In ALL the majority of "null" cells can be shown
to be of B cell lineage by the presence of
cytoplasmic , chain (Vogler et al., 1978) or by gene
rearrangement (Korsmeyer et al., 1981). Studies of
Ig gene rearrangement have been helpful in
determining the monoclonality of lymphoid
tumours, including those of follicular histology,742 E.O. GREGG et al.
where this cannot be established by Ig phenotypic
analysis (Arnold et al., 1983). Similarly this
technique has been used to establish the
monoclonality of lymphomas in transplant patients
(Cleary et al., 1984). A JH probe has been used to
demonstrate Ig gene rearrangement in the
neoplastic cells isolated from one case included in
this study (SA), strongly supporting a neoplastic B
cell origin, (Dr Nigel O'Connor, personal
communication).
We have shown by a variety of techniques that
the neoplastic cells from the lymphomas described
in this report are of B cell origin. However we are
not able to decide on the basis of the present
investigations, whether these cells are at an early
stage of B cell maturation. These tumours may
represent a separate developmental lineage of B
lymphocytes within follicle centres or alternatively
asynchrony between Ig expression and homing to
sites of B cell development, analogous to that
reported in myeloid neoplasms for the development
of cytoplasmic enzymes and surface antigen
expression (Scott et al., 1982). Alternatively failure
to express Ig by the majority of the neoplastic cells
may arise as a consequence of an acquired defect in
production by mechanisms similar to that observed
in myeloma (Williams et al., 1966), by aberrant Ig
gene rearrangement (McIntosh et al., 1983) or by
factors unknown.
This report serves to demonstrate that a co-
ordinated approach is required for the investigation
of B cell neoplasms. If routine immunohistology
and immunological analysis of cell suspensions fails
to demonstrate the cell of origin, functional studies
as described in this report may be useful. However,
in a small number of cases where the B cell origin
remains undetermined the ultimate investigation
would appear to be Ig gene rearrangement.
We acknowledge the Leukaemia Research Fund for
financial support.
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